Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Neuromodulation Devices Market by Technology, Application and Biomaterial Global Opportunity Analysis and Industry Forecast, 2014 – 2022

Thursday, October 20, 2016 0:13
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Neuromodulation Devices Market by Technology, Application and Biomaterial Global Opportunity Analysis and Industry Forecast, 2014 – 2022

 

View full report at Neuromodulation Devices Market by Technology, Application and Biomaterial Global Opportunity Analysis and Industry Forecast, 2014 – 2022

 

 

Summary:

Neuromodulation Devices Market by Technology (Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Spinal Cord Stimulation), Application (Chronic Pain Management, Failed back syndrome, Epilepsy, Tremor, Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s disease, Obsessive-Compulsive Disorder, Migraine) and Biomaterial (Metallic, Polymeric, Ceramic) – Global Opportunity Analysis and Industry Forecast, 2014 – 2022

No. of pages: 168, No. of Tables: 52, List of figures: 42, Category: Life Sciences, Sub Category: Medical Devices, Author: Deepa Tatkare, Price: $4,740

Neuromodulation is the alteration of nerve activity by delivering electrical impulses directly to a target area. Neurological disorders such as epilepsy, Alzheimer disease, cerebrovascular diseases, and Parkinson’s disease affect the central and peripheral nervous system. Bacterial, viral, and fungal infections can also cause neurological disorders. Growth in the Neuromodulation devices market is attributed to increasing prevalence of neurological disorders due to rapidly rising geriatric population, increasing adoption of neuromodulation devices in developed countries, and growing focus of big players, such as Medtronic and Boston Scientific, on R&D in the segment.

The world neuromodulation devices market is estimated to reach $11,717 million by 2022. The market is expected to be driven by the increasing awareness about the safety and efficacy of neuromodulation devices, rising prevalence of neurological disorders and rising number of clinical trials worldwide for the development of innovative technologies in the field of neuromodulators. However, lack of trained healthcare professionals and stringent approval policies restrain the market growth.

The world neuromodulation devices market is segmented on the basis of product type, technology, application, material and geography. Based on product type, it is categorized into internal and external neuromodulation. Based on technology, Internal neuromodulation is segmented into five major segments, namely, deep brain stimulators, sacral nerve stimulators, spinal cord stimulators, vagus nerve stimulators and other neuromodulation devices. Similarly, based on technology external neuromodulation are classified into transcutaneous electrical nerve stimulation and repetitive transcranial magnetic stimulation. Spinal cord stimulators generated the highest revenue in 2015, whereas the deep brain stimulation market is expected to grow fastest by a CAGR of 13.9%. By application, the market is segmented into the following nine segments: failed back syndrome, chronic pain management, epilepsy, tremors, urinary and fecal incontinence, depression, dystonia, gastroparesis, Parkinson’s disease, obsessive-compulsive disorder, migraine, depression and other applications. By biomaterial type, it is divided into metallic biomaterials, ceramic biomaterials and polymeric biomaterials.

Geographically, it is segmented into North America, Europe, Asia-Pacific and LAMEA. Presently, North America occupies the largest market share, followed by Europe and Asia-Pacific. Asia-Pacific is expected to witness maximum growth during the forecast period.

Key strategies adopted by major players include increasing focus on clinical trials for the development of innovative technologies, expanding the indications of the currently marketed neuromodulation devices and mergers &acquisitions. For instance, Boston Scientific is conducting clinical trials oftheir occipital nerve stimulator precision system for chronic migraine. In the year 2015, St. Jude Medical acquired Spinal Modulation Inc. for their AxiumNeurostimulator System.

The report provides comprehensive analyses of the key players operating in the neuromodulation devices market such as Medtronic plc, St. Jude Medical, Inc., LivaNova PLC, Boston Scientific Corporation, Aleva Neurotherapeutics SA, BioControl Medical, Bioness Inc., EnteroMedics Inc, Nevro Corporation and NeuroPace Inc.

Key Market Benefits

• The study provides an in-depth analysis of the world neuromodulation devices market with current trends and future estimations to elucidate the imminent investment pockets.

• The report provides a quantitative analysis from 2014 to 2022, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.

• Extensive analysis by product helps in understanding the various types of devices used for the treatment of neurological diseases and other related conditions.

• Competitive intelligence highlights the business practices followed by leading players across various regions.

• SWOT analysis studies the internal environment of the leading companies for strategy formulation.

 

Key Market Segments

The world neuromodulation devices market is segmented based on technology, applications, material and geography.

By Technology

• Internal neuromodulation

 

• Deep Brain Stimulation  

 

• Sacral Nerve Stimulation  

 

• Vagus Nerve Stimulation

 

• Spinal Cord Stimulation

 

• Other Neuromodulation Technologies

 

• External neuromodulation

 

• Transcutaneous Electrical Nerve Stimulation

 

• Transcranial Magnetic Stimulation

 

By Application

• Chronic Pain Management

• Failed back syndrome

• Epilepsy

• Tremor

• Urinary and Fecal Incontinence

• Depression

• Dystonia

• Gastroparesis

• Parkinson’s disease

• Obsessive-Compulsive Disorder

• Migraine

• Other Applications

 

By Biomaterial

o Metallic Biomaterials       

o Polymeric Biomaterials     

o Ceramic Biomaterials   

By Region

• North America    

o U.S.   

o Canada   

o Mexico   

• Europe    

o Germany   

o UK   

o France   

o Italy

o Spain

o Rest of Europe

   

• Asia-Pacific    

o Japan   

o China   

o India

o South Korea

o Malaysia

o Rest of Asia-Pacific

• LAMEA    

o Brazil

o Israel

o South Africa

o Saudi Arabia

o Rest of LAMEA

                                                                                                                                                            

Get Full Report with Table of Contents at http://www.YourResearchHub.com/products/Neuromodulation-Devices-Market-by-Technology-Application-and-Biomaterial-Global-Opportunity-Analysis-and-Industry-Forecast-2014-2022

 

@YourResearchHub :

Whether you’re looking for new product trends or competitive analysis of an existing or emerging market, YourResearchHub.com has the best research offerings and the expertise to make sure you efficiently get the critical information you need. Don’t limit your choices.

Here is a quick insight into the variety of curated knowledge content we offer: 

We’d be glad to assist you with your quest for knowledge. Get in touch today to discuss your needs.

Please call us or write to us:

UK: +44 208123 7101

Email: sales@yourresearchhub.com

Follow Us –
Browse Blog at
http://www.yourresearchhub.com/blogs/news

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.